{
  "main_header": {
    "sid": 10039523,
    "name": "OneSource Speci.",
    "stock_name": "OneSource Speci.",
    "full_name": "OneSource Specialty Pharma Ltd",
    "name_url": "stocks-analysis/onesource-speci",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,496.75",
    "chg": 16.75,
    "chgp": "1.13%",
    "dir": 1,
    "prev_price": "1,480.00",
    "mcapval": "17,128.21 Cr",
    "mcap": "Mid Cap",
    "scripcode": 544292,
    "symbol": "ONESOURCE",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE013P01021",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:24 AM",
    "bse_nse_vol": "67.31 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/onesource-speci-10039523-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 1,
    "sid": "10039523",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/onesource-specialty-pharma-10039523"
  },
  "announcements": [
    {
      "caption": "Announcement Under Regulation 30 SEBI(LODR) Regulations 2015_Updates",
      "datetime": "09-Apr-2025",
      "details": "OneSource secures Brazilian GMP approval for its flagship facility Unit 2",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015",
      "datetime": "29-Mar-2025",
      "details": "Intimation on completion of US-FDA Inspection at Onesource Unit-2 Doddaballapura Bengaluru a manufacturing unit of the Company.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "27-Mar-2025",
      "details": "The trading window for dealing in the securities of the company is closed from April 01 2025 untill 48 hours after the declaration of the financial results for the quarter and year ended March 31 2025",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

No Recent News for the Company

View All News